SCHEMBL21717850

SCHEMBL21717850

c1ccc(-c2ccc(-c3cc4c5ccccc5n5c6ccccc6c(c3)c45)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.39
KDM4E B2RXH2 5/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSD17B10 Q99714 3/20 0.37
TSHR P16473 1/20 0.37
GPR3 P46089 1/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 4/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
HTT P42858 2/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
PLA2G2A P14555 1/20 0.36
PLA2G4A P47712 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21454044 0.98 TSPO (0.38) TSPOKDM4EATML3MBTL1HSD17B10
SCHEMBL21710577 0.98 KDM4E (0.40) TSPOKDM4EATML3MBTL1HSD17B10
SCHEMBL21710687 0.96 KDM4E (0.39) TSPOKDM4EATML3MBTL1HSD17B10
SCHEMBL10015047 0.96 GPR3 (0.39) TSPOKDM4EATML3MBTL1HSD17B10
SCHEMBL24794463 0.94 TSPO (0.46) TSPOKDM4EATML3MBTL1HSD17B10
SCHEMBL16621693 0.94 TSPO (0.46) TSPOKDM4EATML3MBTL1HSD17B10
SCHEMBL23138557 0.94 TSPO (0.46) TSPOKDM4EATML3MBTL1HSD17B10
SCHEMBL16621683 0.94 TSPO (0.46) TSPOKDM4EATML3MBTL1HSD17B10
SCHEMBL15460057 0.94 TSPO (0.40) TSPOKDM4EATML3MBTL1HSD17B10
SCHEMBL15460054 0.94 TSPO (0.40) TSPOKDM4EATML3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029119-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-02 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 US disclosed
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12029119-B2 Organic electroluminescence element and electronic device LEF1, L1CAM, ESR2 TSPO 1263/4885KDM4E 2210/4885ATM 3221/4885
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 TSPO 1263/4885KDM4E 2210/4885ATM 3221/4885
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR51E2, CD99, CTNND1 TSPO 1545/4885KDM4E 2086/4885ATM 2817/4885
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS EML4, EBPL, LEF1 TSPO 789/4885KDM4E 2270/4885ATM 3672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.